81 related articles for article (PubMed ID: 6938006)
1. Renal stone disease--experience from a population study of women in Gothenburg, Sweden.
Bengtsson C; Lennartsson J; Lindquist O; Noppa H
Scand J Urol Nephrol Suppl; 1980; 53():39-43. PubMed ID: 6938006
[TBL] [Abstract][Full Text] [Related]
2. Calcium, phosphate and albumin in serum. A population study with special reference to renal stone formers and the prevalence of hyperparathyroidism in middle-aged men.
Ljunghall S; Hedstrand H; Hellsing K; Wibell L
Acta Med Scand; 1977 Jan; 201(1-2):23-30. PubMed ID: 835367
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological aspects of renal stone disease in Scandinavia.
Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Wikström B
Scand J Urol Nephrol Suppl; 1980; 53():31-8. PubMed ID: 6938005
[No Abstract] [Full Text] [Related]
4. Kidney stone disease. Experiences from Uppsala, Sweden.
Backman U; Danielson BG; Fellström B; Johansson G; Ljunghall S; Wikström B
Scand J Urol Nephrol Suppl; 1980; 53():207-11. PubMed ID: 6937997
[TBL] [Abstract][Full Text] [Related]
5. Renal stone disease in a Swedish district during one year.
Ahlstrand C; Tiselius HG
Scand J Urol Nephrol; 1981; 15(2):143-6. PubMed ID: 7330608
[TBL] [Abstract][Full Text] [Related]
6. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of kidney stones in Iceland: a population-based study.
Indridason OS; Birgisson S; Edvardsson VO; Sigvaldason H; Sigfusson N; Palsson R
Scand J Urol Nephrol; 2006; 40(3):215-20. PubMed ID: 16809263
[TBL] [Abstract][Full Text] [Related]
8. Renal stone disease in Christchurch, New Zealand. Part 1: presentation and epidemiology.
Davidson PJ; Sheerin IG; Frampton C
N Z Med J; 2009 Jun; 122(1297):49-56. PubMed ID: 19649001
[TBL] [Abstract][Full Text] [Related]
9. Frequency of renal stone disease in patients with urinary tract infection.
Jan H; Akbar I; Kamran H; Khan J
J Ayub Med Coll Abbottabad; 2008; 20(1):60-2. PubMed ID: 19024188
[TBL] [Abstract][Full Text] [Related]
10. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
11. [Functional evaluation in patients with kidney calculi].
Stojimirović B
Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
[TBL] [Abstract][Full Text] [Related]
12. Local factors compared with systemic factors in the formation of bladder uric acid stones.
Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
[TBL] [Abstract][Full Text] [Related]
13. Changing gender prevalence of stone disease.
Scales CD; Curtis LH; Norris RD; Springhart WP; Sur RL; Schulman KA; Preminger GM
J Urol; 2007 Mar; 177(3):979-82. PubMed ID: 17296391
[TBL] [Abstract][Full Text] [Related]
14. Pediatric urinary stone disease--does age matter?
Kalorin CM; Zabinski A; Okpareke I; White M; Kogan BA
J Urol; 2009 May; 181(5):2267-71; discussion 2271. PubMed ID: 19296968
[TBL] [Abstract][Full Text] [Related]
15. Renal stone disease. Studies of epidemiology and calcium metabolism.
Ljunghall S
Scand J Urol Nephrol; 1977; (41):1-96. PubMed ID: 615339
[No Abstract] [Full Text] [Related]
16. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
[TBL] [Abstract][Full Text] [Related]
17. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
18. [Study of crystalluria in diabetic patients].
Mbarki M; Jabrane J; Oussama A; Daudon M
Prog Urol; 2005 Jun; 15(3):420-5; discussion 425-6. PubMed ID: 16097146
[TBL] [Abstract][Full Text] [Related]
19. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
[TBL] [Abstract][Full Text] [Related]
20. Urinary stone risk factors in the siblings of patients with calcium renal stones.
Kinder JM; Clark CD; Coe BJ; Asplin JR; Parks JH; Coe FL
J Urol; 2002 May; 167(5):1965-7. PubMed ID: 11956418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
